Showing results (101-110 of 232) with videos related to

Sort By:
Pageof 24
Neuroimage. Clinical|April 21, 2021
Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated referencesAlexandra de Sitter, Jessica Burggraaff, Fabian Bartel, et al.
Neurology|January 2, 2024
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter StudyAngela Vidal-Jordana, Alex Rovira, Willem Calderon, et al.
Annals of Neurology|March 1, 2013
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosisValerio Chiurchiù, Maria Teresa Cencioni, Elisa Bisicchia, et al.
Neurology and Therapy|August 2, 2017
A Comprehensive Review on Copemyl®Pietro Annovazzi, Antonio Bertolotto, Vincenzo Brescia Morra, et al.
Clinical Neuropharmacology|June 4, 2008
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa studyAlessandra Lugaresi, Valentina Durastanti, Claudio Gasperini, et al.
Neurology|July 24, 2019
Effect of dalfampridine on information processing speed impairment in multiple sclerosisLaura De Giglio, Francesca De Luca, Flavia Gurreri, et al.
World Neurosurgery|October 6, 2022
Is Mechanical Thrombectomy or Thrombolysis Universally Cost-Effective? A Systematic Review of the LiteratureGianluca De Rubeis, Sebastiano Fabiano, Luca Bertaccini, et al.
JAMA Neurology|October 13, 2015
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple SclerosisSerena Ruggieri, Maria Petracca, Aaron Miller, et al.
Scientific Reports|May 12, 2018
Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitisAlessia Farinazzo, Stefano Angiari, Ermanna Turano, et al.
Journal of Neurology|August 10, 2025
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensusMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Pageof 24